Brainstorm Cell Therapeutics Inc.
BCLI
$0.69
$0.00-0.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.43M | -2.11M | -2.90M | -2.86M | -2.97M |
| Total Depreciation and Amortization | 48.00K | 48.00K | 51.00K | 52.00K | 53.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 322.00K | 157.00K | 503.00K | 717.00K | 73.00K |
| Change in Net Operating Assets | 1.32M | 799.00K | -1.15M | 464.00K | 1.80M |
| Cash from Operations | -740.00K | -1.10M | -3.50M | -1.63M | -1.05M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 12.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 12.00K |
| Total Debt Issued | 582.00K | -- | -- | 900.00K | -- |
| Total Debt Repaid | 199.00K | -- | -1.10M | -- | -- |
| Issuance of Common Stock | -- | 313.00K | 3.35M | 685.00K | 1.06M |
| Repurchase of Common Stock | -1.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -- | 450.00K | 1.50M | -- |
| Cash from Financing | 780.00K | 313.00K | 2.70M | 3.09M | 1.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.00K | -789.00K | -801.00K | 1.46M | 22.00K |